As a senior research analyst for First Light, Steve Boscoe plays a significant role in the execution of the firm’s investment processes, including identifying and analyzing prospective and existing portfolio investments.
Boscoe has been investing in equities across the health care spectrum since 2000. Before joining First Light, he managed a therapeutic portfolio consisting of pharmaceutical, biotechnology, specialty pharmaceutical and generic companies for Citadel Global Equities in San Francisco, Calif. Prior to this position, Boscoe was a founding partner and senior health care analyst for Blue Jay Capital Management where he invested across the entire health care universe with a focus on therapeutics and health care services. He also was a founding partner and senior health care analyst for Expo Capital Management, a health care sector hedge fund, where he covered the biotechnology, pharmaceutical, medical technology, diagnostics and health care services industries. Additionally, Boscoe was a senior health care analyst for Vantis Capital Management and Seneca Capital Management; a biotechnology equity research analyst and equity research senior associate for Morgan Stanley; and a managed care equity research associate for Credit Suisse First Boston/Donaldson, Lufkin & Jenrette.
Boscoe earned a master of business administration (MBA) degree from New York University’s Stern Graduate School of Business and a master of physical therapy degree from the University of Southern California. He holds a bachelor of science degree in biomechanics from the University of California, Davis.